
As we prepare for potential upcoming launches, Karyopharm is seeking to connect with experienced Medical Science Liaisons across the United States. Medical Science Liaisons at Karyopharm serve as trusted scientific partners to the medical community, engaging thought leaders and healthcare professionals across hematologic malignancies and solid tumors. Areas of focus may include multiple myeloma, myelofibrosis, endometrial cancer, and select rare diseases aligned with near-term launch readiness and longer-term pipeline development.
RESPONSIBILITIES:
At Karyopharm, we live and demonstrate our ICARE values every day!
If you want to do something that matters, this work matters. Patients drive our passion to pioneer novel cancer therapies. That’s why we’ve built an environment centered around support, flexibility, and a shared mission.
Creating and delivering medicine for cancer can only be done through focus, dedication, and heart. We hire exceptional people and trust each other to work in whatever way lets us, be us – whether that’s onsite, from home, or anywhere in between.
What do you get when you pair an extraordinary mission with a culture of flexibility and empowerment? We invite you to find out and join us on this incredible mission.
Check out our Culture Video!
What We Offer:
In addition to our exciting, supportive, and intellectually challenging global workspaces(s), teamembers enjoy a comprehensive and generous benefits package (active on day one) that makes them more productive and contributes directly to the development of their professional skills.
In the U.S., the salary range for this position is $190K to $210K per year, which factors in various geographic regions. The base pay actually offered will take into account internal equity and also may vary depending on the candidate’s geographic region, job-related knowledge, skills, and experience among other factors

Karyopharm Therapeutics Inc. is a commercial-stage pharmaceutical company whose dedication to pioneering novel cancer therapies is fueled by a belief in the extraordinary strength and courage of patients with cancer. As an organization, Karyopharm is on a mission to improve lives and defeat cancer. In its role as leaders in XPO1 inhibition, Karyopharm delivers on its mission by creating a focused pipeline that targets multiple high unmet need cancer indications, including multiple myeloma, endometrial cancer,
myelofibrosis, and diffuse large B-cell lymphoma (DLBCL).